1996 CE
Triple antiretroviral therapy for HIV
Epidemics & public health · VIH/sida · Antirretrovirales · Resistencia antimicrobiana
In 1996, trials showed that three-drug combinations could durably suppress HIV replication to very low levels and create a higher barrier to resistance than monotherapy. This transformed treatment prospects for people able to receive it, although early regimens had adverse effects, complexity, and highly unequal access.
Precision, calendar, and review
- Start
- year · no uncertainty qualifier in this record
- Calendar and convention
- Historical-era years; the source calendar is not identified. No conversion of days is assumed.
- Year zero
- The scale goes from 1 BCE to 1 CE without year zero. Changing era names changes labels only.
- Documentary review
- Date not recorded
Reading the date: point event.
Sources
- pubweb-prod.niaid.nih.gov (opens in a new tab)
Source provenance and scope
- Publication date
- Pending verification: the source could not be accessed
- Bibliographic date checked
- 2026-09-23
The correspondence between this reference and individual claims has not yet been itemized.
This record is an editorial synthesis. Consult the sources to check claims and their limits. Chronological relationships alone do not establish causation.